Interestingly, in a variety of hematological and lymphoid cancers, including Burkitt’s lymphoma and DLBCL, the Gα13 /RhoA signaling axis has been revealed to have a tumor-suppressive effect [138,139,140]. Here, RHOA is linked to lymphoma.